Amyloid β-Protein (Human, 1-43)

Documents

Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr
: (Trifluoroacetate Form)
: (M.W. 4615.1) C₂₀₇H₃₁₈N₅₆O₆₂S

Package	Price(Yen)	Availability
Vial 0.5 mg	35,000	Ships within 1-3 business days
Bulk Request

Solubility: 0.1% NH₄OH or DMSO (1 mM)

A. Tamaoka, T. Kondo, A. Odaka, N. Sahara, N. Sawamura, K. Ozawa, N. Suzuki, S. Shoji, and H. Mori, Biochem. Biophys. Res. Commun., 205, 834 (1994). (Pharmacol.)
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole, Science, 274, 99 (1996). (Pharmacol.)
K. Duff, C. Eckman, C. Zehr, X. Yu, C.-M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy, and S. Younkin, Nature, 383, 710 (1996). (Pharmacol.)
T. Kawarabayashi, Y. Igeta, M. Sato, A. Sasaki, E. Matsubara, M. Kanai, Y. Tomidokoro, K. Ishiguro, K. Okamoto, S. Hirai, and M. Shoji, Brain Res., 765, 343 (1997). (Pharmacol.)
A. Rauk, Chem. Soc. Rev., 38, 2698 (2009). (Review)

Data Sheet